Remdesivir May Be Lifesaving for COVID-19 Patients, Yet Toxic for US-EU Relations

BRUSSELS (Sputnik), Luc Rivet – Remdesivir, an antiviral drug produced by the California-based company Gilead Sciences, has become the first treatment for COVID-19 to receive the backing of the European Medicines Agency and at the same time a bone of contention between the EU and the US after the latter allegedly bought up its global supply.
Source: Remdesivir May Be Lifesaving for COVID-19 Patients, Yet Toxic for US-EU Relations